These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22966305)

  • 21. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
    Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
    Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer.
    Barczak W; Rozwadowska N; Romaniuk A; Lipińska N; Lisiak N; Grodecka-Gazdecka S; Książek K; Rubiś B
    Oncol Lett; 2016 Mar; 11(3):2305-2309. PubMed ID: 26998167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
    Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
    Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rapamycin on the mechanistic target of rapamycin (mTOR) pathway and telomerase in breast cancer cells.
    Gopalakrishnan K; Venkatesan S; Low ESH; Hande MP
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):103-113. PubMed ID: 30442335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
    Thriveni K; Raju A; Kumar RV; Krishnamurthy S; Chaluvarayaswamy R
    Clin Breast Cancer; 2019 Feb; 19(1):27-34. PubMed ID: 30217473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative lengthening of telomeres in mammalian cells.
    Henson JD; Neumann AA; Yeager TR; Reddel RR
    Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of telomeres and telomerase in endometrial pathology.
    Hapangama DK; Kamal A; Saretzki G
    Hum Reprod Update; 2017 Mar; 23(2):166-187. PubMed ID: 27979878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Super-telomeres in transformed human fibroblasts.
    Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
    Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
    Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
    Min J; Wright WE; Shay JW
    Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
    Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
    Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomere length homeostasis requires that telomerase levels are limiting.
    Cristofari G; Lingner J
    EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
    Strahl C; Blackburn EH
    Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
    Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
    Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of telomere-mimic phosphorothioate oligodeoxy nucleotides (S-ODNS) on human tumor cell lines.
    Saeki T; Takashima S; Tachibana M; Koga M; Hiyama E; Salomon DS; Holland JF; Ohnuma T
    Oncology; 1999 Oct; 57 Suppl 2():27-36. PubMed ID: 10545800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells.
    Cerone MA; Londoño-Vallejo JA; Autexier C
    Mol Cancer Ther; 2006 Jul; 5(7):1669-75. PubMed ID: 16891452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.